Depression in patients with irritable bowel syndrome in Jos, Nigeria
- PMID: 17203531
- PMCID: PMC4087553
- DOI: 10.3748/wjg.v12.i48.7844
Depression in patients with irritable bowel syndrome in Jos, Nigeria
Abstract
Aim: To study the brain-gut interaction and the effect of behavioral or psychiatric conditions on irritable bowel syndrome (IBS) in an African population.
Methods: IBS was diagnosed using the Rome II diagnostic criteria. The entry of each patient was confirmed following detailed explanations of the questions. Four hundred and eighteen patients were studied. Subjects satisfying the Rome II criteria for IBS were physically examined and stool microscopy was done to identify the presence of "alarm factors". Depression was diagnosed using the symptom-check list adapted from the Research Diagnostic Criteria (DSM-IV) of the American Psychiatric Association.
Results: Seventy-five (56.8%) of the 132 IBS patients were depressed whereas only 54 (20.1%) of the 268 non-IBS patients were depressed. There was a significant relationship between IBS and depression (chi2 = 54.29, Odds ratio = 5.21, 56.8 +/- 8.4 vs 20.1 +/- 5.2, P = 0.001). Even though constipation predominant IBS patients were more likely to be depressed, no significant relationship was found between the subtype of IBS and depression (chi2 = 0.02, OR = 0.95, P = 0.68).
Conclusion: IBS is significantly associated with major depression but not gender and bowel subtypes of the patients. Patients with IBS need to be evaluated for depression due to the highly significant relationship between the two conditions.
Figures
Similar articles
-
Irritable bowel syndrome among patients attending General Outpatients' clinics in Jos, Nigeria.Eur J Gastroenterol Hepatol. 2007 Sep;19(9):795-9. doi: 10.1097/MEG.0b013e3282202ba5. Eur J Gastroenterol Hepatol. 2007. PMID: 17700266
-
Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1137-43. doi: 10.1111/j.1440-1746.2007.05245.x. Epub 2007 Dec 7. J Gastroenterol Hepatol. 2008. PMID: 18070012
-
Prevalence of irritable bowel syndrome: a community survey in an African population.Ann Afr Med. 2009 Jul-Sep;8(3):177-80. doi: 10.4103/1596-3519.57241. Ann Afr Med. 2009. PMID: 19884695
-
[Irritable bowel syndrome--irritable bowel or irritable mind?].Pol Merkur Lekarski. 2012 Jan;32(187):64-9. Pol Merkur Lekarski. 2012. PMID: 22400184 Review. Polish.
-
Anxiety and depression in Indian patients with irritable bowel syndrome: A meta-analysis.Indian J Gastroenterol. 2023 Feb;42(1):32-39. doi: 10.1007/s12664-022-01300-0. Epub 2023 Jan 19. Indian J Gastroenterol. 2023. PMID: 36656484
Cited by
-
The burden of irritable bowel syndrome and chronic constipation on health-related quality of life in black Africans: a comparison with healthy control subjects in Côte d'Ivoire, West Africa.Clin Exp Gastroenterol. 2019 Aug 2;12:355-365. doi: 10.2147/CEG.S192563. eCollection 2019. Clin Exp Gastroenterol. 2019. PMID: 31447575 Free PMC article.
-
Prevalence of psychiatric disorders in patients of irritable bowel syndrome fulfilling Rome IV criteria: An observational study.J Family Med Prim Care. 2025 Apr;14(4):1478-1485. doi: 10.4103/jfmpc.jfmpc_1196_23. Epub 2025 Apr 25. J Family Med Prim Care. 2025. PMID: 40396068 Free PMC article.
-
Central nervous system plus autonomic nervous system disorders responsible for gastrointestinal and pancreatobiliary diseases.Dig Dis Sci. 2009 Mar;54(3):458-70. doi: 10.1007/s10620-008-0369-9. Epub 2008 Jul 16. Dig Dis Sci. 2009. PMID: 18629642 Review.
-
Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C.Clin Pract Epidemiol Ment Health. 2008 May 23;4:15. doi: 10.1186/1745-0179-4-15. Clin Pract Epidemiol Ment Health. 2008. PMID: 18500977 Free PMC article.
-
A Review on Exploring the Potential of Vincamine and Melatonin as an Effective Anti-depressant Agent.Curr Drug Res Rev. 2024;16(3):395-402. doi: 10.2174/2589977515666230825095036. Curr Drug Res Rev. 2024. PMID: 37622717 Review.
References
-
- Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med. 2001;344:1846–1850. - PubMed
-
- Dunphy RC, Verne GN. Drug treatment options for irritable bowel syndrome: managing for success. Drugs Aging. 2001;18:201–211. - PubMed
-
- Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–1580. - PubMed
-
- Hasler WL, Owyang C. Irritable Bowel Syndrome. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, et al., editors. Textbook of Gastroenterology. Philadelphia: JB Lippincott Company; 1991. pp. 1696–1714.
-
- Olubuyide IO, Olawuyi F, Fasanmade AA. A study of irritable bowel syndrome diagnosed by Manning criteria in an African population. Dig Dis Sci. 1995;40:983–985. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical